Los Angeles, California
Phase 1 cancer trials in Los Angeles, CA
156 Phase 1 cancer studies are recruiting participants at sites in Los Angeles as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Los Angeles at a glance
- 156 studies are recruiting at a site in Los Angeles.
- By phase: Early Phase 1 (5), Phase 1 (63), Phase 1/2 (88).
- By sponsor: industry (129), university, hospital or other (24), government (3).
- By research area: Breast Cancer (55), Lung Cancer (49), Lymphoma (22), Prostate Cancer (13), Pancreatic Cancer (10), Melanoma (7).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Los Angeles
Basic details from each study's public record (the 30 most recently updated of 156). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Study site
- University of Southern California Cancer Center
- Registry record
- NCT05683418 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- USC Norris Comprehensive Cancer Center
- Registry record
- NCT06253871 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study sites
- Ellison Medical Institute · University of California Los Angeles · Valkyrie Clinical Trials
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- START Los Angeles
- Registry record
- NCT07488676 · updated
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Phase 1
- Ages 12 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Keck Medicine of USC Koreatown · Los Angeles General Medical Center · USC / Norris Comprehensive Cancer Center
- Registry record
- NCT05372640 · updated
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Immunomic Therapeutics, Inc.
- Study site
- The Angeles Clinic and Research Institute (TACRI)
- Registry record
- NCT07652242 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- UCLA Health 200 Medical Plaza
- Registry record
- NCT03424005 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- University of California - Los Angeles
- Registry record
- NCT06586957 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- University of California Los Angeles Medical Center
- Registry record
- NCT05579366 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- UCLA Department of Medicine-Hematology/Oncology
- Registry record
- NCT06465069 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in Los Angeles
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study sites
- The Angeles clinic - A cedars SINAI AFFILIATE · USC Norris Comprehensive Cancer Center
- Registry record
- NCT05786924 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- USC/Norris Comprehensive Cancer Center
- Registry record
- NCT06444815 · updated
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EpiBiologics
- Study site
- Site 105 - START Los Angeles
- Registry record
- NCT07462377 · updated
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- UCLA Hematology Oncology - Main Site
- Registry record
- NCT07111520 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Valkyrie Clinical Trials
- Registry record
- NCT04886804 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Valkyrie Clinical Trials
- Registry record
- NCT07080242 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT07458347 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Cedars-Sinai Medical Center
- Registry record
- NCT07020221 · updated
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study sites
- California Research Institute · Valkyrie Clinical Trials
- Registry record
- NCT04198766 · updated
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Administrative Address: UCLA Hematology/Oncology · Ronald Reagan UCLA Medical Center
- Registry record
- NCT07090499 · updated
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
- Early Phase 1
- Ages 22 and older
- All sexes
- Sponsor
- Jonsson Comprehensive Cancer Center
- Study site
- UCLA / Jonsson Comprehensive Cancer Center
- Registry record
- NCT07235280 · updated
A 2-part Phase 1/2 Open-label Trial on ODM-212
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Orion Corporation, Orion Pharma
- Study site
- Valkyrie Clinical Trials
- Registry record
- NCT07563738 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Cedars-Sinai Cancer at Cedars Sinai Medical Center
- Registry record
- NCT06706076 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- USC Norris Comprehensive Cancer Center
- Registry record
- NCT07397338 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Los Angeles
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07332455 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in Los Angeles
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT04726241 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT06173518 · updated
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Cedar Sinai Cancer Center ( Site 0119)
- Registry record
- NCT07519772 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Study site
- Children's Hospital Los Angeles
- Registry record
- NCT05848687 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of California, Los Angeles (UCLA) - Medical Center
- Registry record
- NCT07226843 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Ask about studies near Los Angeles
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
377 studies recruiting across 44 cities.
Duarte
109 studies recruiting.
San Francisco
66 studies recruiting.
La Jolla
37 studies recruiting.
Orange
36 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections